| Literature DB >> 24078868 |
David J Moore1, Jessica L Montoya, Kaitlin Blackstone, Alexandra Rooney, Ben Gouaux, Shereen Georges, Colin A Depp, J Hampton Atkinson, The Tmarc Group.
Abstract
The feasibility, use, and acceptability of text messages to track methamphetamine use and promote antiretroviral treatment (ART) adherence among HIV-infected methamphetamine users was examined. From an ongoing randomized controlled trial, 30-day text response rates of participants assigned to the intervention (individualized texting for adherence building (iTAB), n = 20) were compared to those in the active comparison condition (n = 9). Both groups received daily texts assessing methamphetamine use, and the iTAB group additionally received personalized daily ART adherence reminder texts. Response rate for methamphetamine use texts was 72.9% with methamphetamine use endorsed 14.7% of the time. Text-derived methamphetamine use data was correlated with data from a structured substance use interview covering the same time period (P < 0.05). The iTAB group responded to 69.0% of adherence reminder texts; among those responses, 81.8% endorsed taking ART medication. Standardized feedback questionnaire responses indicated little difficulty with the texts, satisfaction with the study, and beliefs that future text-based interventions would be helpful. Moreover, most participants believed the intervention reduced methamphetamine use and improved adherence. Qualitative feedback regarding the intervention was positive. Future studies will refine and improve iTAB for optimal acceptability and efficacy. This trial is registered with ClinicalTrials.gov NCT01317277.Entities:
Year: 2013 PMID: 24078868 PMCID: PMC3776360 DOI: 10.1155/2013/585143
Source DB: PubMed Journal: AIDS Res Treat ISSN: 2090-1240
Participant intervention feedback as provided on a standardized questionnaire: text message ease of understanding/problems, satisfaction, self-perceived efficacy, and future direction.
| Question | iTAB ( | Control ( |
|---|---|---|
|
| ||
| I had difficulties understanding the text messages | ||
| Not at all | 16 (94%) | 8 (89%) |
| A little bit | 0 (0%) | 1 (11%) |
| Moderately | 1 (6%) | 0 (0%) |
| Quite a bit | 0 (0%) | 0 (0%) |
| Very much | 0 (0%) | 0 (0%) |
| Receiving text messages interfered with my daily activities | ||
| Not at all | 13 (76%) | 9 (100%) |
| A little bit | 1 (6%) | 0 (0%) |
| Moderately | 2 (12%) | 0 (0%) |
| Quite a bit | 0 (0%) | 0 (0%) |
| Very much | 1 (6%) | 0 (0%) |
|
| ||
| How would you rate your overall satisfaction of participating in this study? | ||
| Extremely unsatisfied | 0 (0%) | 1 (11%) |
| Somewhat unsatisfied | 0 (0%) | 0 (0%) |
| Neither unsatisfied nor satisfied | 1 (6%) | 2 (22%) |
| Somewhat satisfied | 5 (29%) | 2 (22%) |
| Extremely satisfied | 11 (65%) | 4 (44%) |
|
| ||
| Do you feel that the daily text message, “Have you done anything in the past 24 hours?” made you use methamphetamine | ||
| A lot less | 6 (35%) | 2 (22%) |
| A little less | 6 (35%) | 3 (33%) |
| About the same | 4 (24%) | 4 (44%) |
| A little more | 0 (0%) | 0 (0%) |
| A lot more | 1 (6%) | 0 (0%) |
| The intervention made my overall ART medication adherence | ||
| Much worse | 0 (0%) | 1 (11%) |
| A little worse | 2 (12%) | 0 (0%) |
| About the same | 5 (29%) | 3 (33%) |
| A little better | 4 (24%) | 5 (56%) |
| Much better | 6 (35%) | 0 (0%) |
|
| ||
| I would participate in similar studies in the future | ||
| Not at all | 0 (0%) | 1 (11%) |
| A little bit | 1 (6%) | 0 (0%) |
| Moderately | 3 (18%) | 0 (0%) |
| Quite a bit | 1 (6%) | 1 (11%) |
| Very much | 12 (71%) | 7 (78%) |
| A text messaging intervention could be helpful to me in the future | ||
| Not at all | 1 (6%) | 1 (11%) |
| A little bit | 1 (6%) | 0 (0%) |
| Moderately | 3 (18%) | 3 (33%) |
| Quite a bit | 2 (12%) | 1 (11%) |
| Very much | 10 (59%) | 4 (44%) |
Note: no significant differences were observed for any of the reported variables.
Descriptive characteristics of the study groups (N = 29).
| iTAB ( | Control ( | |
|---|---|---|
| Demographics | ||
| Age; mean (SD) | 46.8 (8.3) | 52.4 (6.6) |
| Education; mean (SD) | 13.2 (2.7) | 14.3 (2.7) |
| Male; % (#) | 90.0% (18) | 100.0% (9) |
| Caucasian; % (#) | 55.0% (11) | 33.3% (3) |
| HIV disease characteristics | ||
| CD4 count; median [IQR]a | 586.5 [140.5, 974.8] | 606.5 [198.3, 1053.8] |
| Nadir CD4 count; median [IQR]b | 148 [14.8, 493.8] | 235 [153, 362.5] |
| HIV RNA plasma; median [IQR]c | 1.6 [1.6, 1.9] | 1.6 [1.6, 3.2] |
| RNA plasma detectable % (#)d | 26.3% (5) | 37.5% (3) |
| AIDS % (#)e | 50.0% (2) | 50.0% (2) |
| Time since first positive test; mean (SD)f | 125.5 (101.0) | 201.1 (104.9) |
| Meth use characteristics | ||
| Age of first use; mean (SD)g | 30.0 (12.0) | 29.2 (14.6) |
| Total days used; mean (SD) | 1634.8 (2190.8) | 1516.2 (1551.5) |
| Total quantity used; mean (SD)h | 1058.7 (1663.4) | 1593.4 (2396.4) |
Key: a n = 8, bNadir CD4 count is self-reported, n = 16; cin log copies/mL, n = 27; d<50 cp/mL, n = 27; eAIDS status based on the 1993 CDC classification scheme, n = 8; ftime since first positive test is calculated in months, n = 8; g n = 25, htotal quantity is in grams. Note: no significant differences were observed for any of the reported variables.
Figure 1Response patterns for (a) medication adherence reminder text messages and (b) methamphetamine-use text messages. Note: ∗ Sample size represents number of messages sent to participants not the number of participants on study.